Boston, MA - June 11, 2019 - Ryan Kelly, the Associate Director of Business Development at Abveris, will give a talk about our advanced immunization strategies and antibody discovery platform technologies at the Future of Drug Discovery and Development Symposium hosted by ACROBiosystems and Biocytogen.
The symposium will be held on Thursday June 13, 2019 from 1-6PM in Cambridge.
Register for free to attend the symposium on Eventbrite.
Join the symposium to learn more about cutting-edge therapeutic antibody discovery technologies and the latest research in biologics drug development. The conference is free to attend, light refreshments and dinner will be provided.
Confirmed Speakers:
Chun-Nan Chen
CEO and CSO, Single Cell Technology
Qingcong Lin
CEO, Biocytogen Boston Corp
Stephen Gillies
CSO, LinkedUp Bioscience Inc
Johanna Lahdenranta
Director of In Vivo Pharmacology, Bicycle Therapeutics
Ryan Kelly
Associate Director, BD at Abveris, Co-Founder at AbX Biologics
Xiaodong Li
Associate of Patent and Intellectual Property, Choate, Hall & Stewart LLP
Click here to learn more about the symposium.
Event Details & Address:
Thursday June 13, 2019 from 1-6PM
Residence Inn Boston Cambridge
120 Broadway, Six Cambridge Center
Cambridge, MA
